ADMA Biologics IncADMA
▼ ネガティブ規制関連度
Investigation into fiduciary breaches, inadequate internal controls, channel-stuffing, and undisclosed related-party transactions.
資産への影響 4
Biotech & Genomic Medicine
ADMA Biologics Inc
Erasca IncERAS
▼ ネガティブ規制関連度
Investigation into improper comparisons, undisclosed IP risks, patient death, and patent infringement allegations.
Cybersecurity & Digital Trust
CommVault Systems IncCVLT
▼ ネガティブ規制関連度
Investigation into allegedly misleading statements about annual recurring revenue growth guidance for fiscal year 2026.
Industrials
Hub Group IncHUBG
▼ ネガティブ規制関連度
Investigation into material misstatements due to premature revenue recognition and understated transportation costs.